...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Oral oncology >Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma
【24h】

Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma

机译：抗EGFR试剂，西妥昔单抗或Nimotuzuzub的有益效果与晚期鼻咽癌的同时进行化学疗法组合

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: This study aimed to evaluate the efficacy and safety in locoregionally advanced nasopharyngeal carcinoma (NPC) patients receiving concurrent chemoradiotherapy (CCRT) plus Cetuximab (CTX) or Nimotuzumab (NTZ) compared to those receiving induction chemotherapy (IC) plus CCRT.
机译：目的：该研究旨在评估与接受诱导化疗（IC）加上CCRT的促进化学疗法（CCRT）加入酸疗法（CCRT）加入的鼻咽癌（CCRT）或Nimotuzumab（NTZ）的疗效和安全性。

著录项

  • 来源
    《Oral oncology》 |2018年第2018期|共8页
  • 作者

    Lin Mei; You Rui; Liu You-Ping; Zhang Yi-Nuan; Zhang Hao-Jiong; Zou Xiong; Yang Qi; Li Chao-Feng; Hua Yi-Jun; Yu Tao; Cao Jing-Yu; Li Ji-Bin; Mo Hao-Yuan; Guo Ling; Lin Ai-Hua; Sun Ying; Qian Chao-Nan; Ma Jun; Mai Hai-Qiang; Chen Ming-Yuan;

  • 作者单位

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc State Key Lab Oncol South China Collaborat Innovat Ctr Canc Med;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc State Key Lab Oncol South China Collaborat Innovat Ctr Canc Med;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Sch Publ Hlth Dept Med Stat &

    Epidemiol 74 Zhongshan Second Rd Guangzhou;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

    Sun Yat Sen Univ Ctr Canc Dept Nasopharyngeal Carcinoma 651 Dongfeng East Rd Guangzhou 510060;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 耳鼻咽喉科学;
  • 关键词

    Nasopharyngeal carcinoma; IMRT; Concurrent chemoradiotherapy; Nimotuzumab; Cetuximab; Survival outcome; Adverse events;

    机译：鼻咽癌;IMRT;同时进行化学疗法;Nimotuzumab;西妥昔单抗;生存结果;不良事件;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号